james rollins' presentation

17
www.CancerSupportCommunity.org Uniting The Wellness Community and Gilda’s Club Worldwide Working with Regulators: A Focus on CMS An Educational Program of the Cancer Policy Institute at the Cancer Support Community in Partnership with Uniting a Community (UaC): Policy, Advocacy, Education and Action Network

Upload: cancersupportcomm

Post on 16-Jul-2015

589 views

Category:

Health & Medicine


0 download

TRANSCRIPT

Page 1: James Rollins' Presentation

www.CancerSupportCommunity.org Uniting The Wellness Community and Gilda’s Club Worldwide

Working with Regulators: A Focus on CMS An Educational Program of the

Cancer Policy Institute at the Cancer Support Community in Partnership with Uniting a Community (UaC): Policy, Advocacy, Education and Action Network

Page 3: James Rollins' Presentation

NCD Definitions in SSA

1862(l)(6) National and local coverage determination defined.—For purposes of this subsection—

(A) National coverage determination.—The term “national coverage determination” means a determination by the Secretary with respect to whether or not a particular item or service is covered nationally under this title

Page 4: James Rollins' Presentation

What is a Covered Service?

• which, if subject to FDA review, has been

approved or cleared for at least one indication;

• which falls within a Medicare Benefit Category

(generally found in §1861 of the Act);

• which is not statutorily excluded based on

§1862(a)(2)-(15) of the Act;

• which is reasonable and necessary based on

§1862(a)(1)

Generally, an item or service:

Page 5: James Rollins' Presentation

Reasonable & Necessary

• Sufficient level of confidence that the evidence is adequate to conclude that the item or service: – Improves health outcomes

– Is generalizable to the Medicare population

– Is generalizable to general provider community

Page 6: James Rollins' Presentation

PATIENT

Usual Workup

Usual Therapy

Usual Outcome

Workup + New Test

Different Therapy

Better Outcome

Worse Outcome

Page 7: James Rollins' Presentation

The Preferred Road to Diagnostic and Therapeutic Coverage

Diagnostic

Provide adequate evidence that

The incremental information obtained by new diagnostic technology compared to alternatives

Changes physician recommendations

Resulting in changes in therapy

That improve clinically meaningful health outcomes

In Medicare beneficiaries

Therapeutic

Provide adequate

evidence that

The new therapeutic

intervention compared to

alternatives

Results in improve

clinically meaningful

health outcomes

• In Medicare beneficiaries

Page 8: James Rollins' Presentation

Health Outcomes of Interest

• Longer life and improved function/participation

• Longer life with arrested decline

• Significant symptom improvement allowing better function/participation

• Reduced need for burdensome tests and treatments

• Longer life with declining function/participation

• Improved disease-specific survival without improved overall survival

• Surrogate test result better

• Image looks better

• Doctor feels confident

More Impressive Less Impressive

Medicare has stated publicly that as a matter of policy that it does not generally consider cost in making national coverage determinations.

Page 9: James Rollins' Presentation

What prompts NCDs?

• External request (statutory)

– Current national non-coverage policy

– Substantial LCD variation

• Internally generated

– Extensive literature or important new

study

– Technological advance with potential

major clinical or economic impact

– Major concerns about inappropriate use

Page 10: James Rollins' Presentation

NCD Process

• Formal Request (30 day comment period)

• Benefit Category Determination

• Review of evidence by CMS

• Technology Assessment/MEDCAC

• Proposed Determination (30 day comment period)

• Final Determination posted on CMS Web site 60 days later

10

Page 11: James Rollins' Presentation

MEDICARE NATIONAL COVERAGE PROCESS

Staff Review

Proposed Decision

Memorandum Posted

National Coverage Request

MEDCAC

External Technology Assessment

6 months

Reconsideration

Staff Review

Public Comment

Final Decision Memorandum

and Implementation

Instructions

30 days 60 days

9 months

Preliminary Discussions

Benefit Category

Departmental Appeals Board

Page 12: James Rollins' Presentation

12

Evidence for NCDs

• Medical Literature

Peer Reviewed Journal

Medical texts

• Technology Assessments thru AHRQ

Evidence Based Practice Centers

• Medicare Evidence Development and Coverage

Advisory Committee (MEDCAC)

Page 13: James Rollins' Presentation

MEDCAC Medicare Evidence Development Coverage Advisory

Committee

• Meets on controversial issues

• Votes only on the quality of the evidence and not on a coverage determination

• Not necessarily on NCDs – Usual Care of Chronic Wounds 2006

Page 14: James Rollins' Presentation

14

Evidence Deficits

• No evidence

• Standard measures missing

• Short term follow-up to studies

• Lack of comparative effectiveness

• Generalizability for Medicare beneficiaries

Page 15: James Rollins' Presentation

National Coverage Determinations

• National Coverage

• National Non-Coverage

• National Coverage with Limitations

• Contractor Discretion

Page 16: James Rollins' Presentation

Reconsideration of NCD

• An NCD Reconsideration may be requested when:

An NCD currently exists, any individual or entity may request that we reconsider any provision of that NCD by filing an acceptable request for an NCD reconsideration.

1) Additional material medical and/or scientific information that was not considered during the initial review, that is, results from new clinical trials, new scientific or medical publications, or studies supporting the request

1) Arguments that our conclusion materially misinterpreted the existing evidence at the time the NCD was made.

Page 17: James Rollins' Presentation

www.CancerSupportCommunity.org Uniting The Wellness Community and Gilda’s Club Worldwide

Working with Regulators: A Focus on CMS was made possible thanks to the support of GlaxoSmithKline